Angcot, Jeralyn .
HRN: 28-32-19 Sex: FemalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/24/2025
CEFUROXIME 500MG (TAB)
12/24/2025
12/30/2025
PO
500 Mg
BID
Thickly MSAF, Perenial 3rd Degree Laceration
Checking Initial Appropriateness
12/24/2025
METRONIDAZOLE 500MG (TAB)
12/24/2025
12/30/2025
PO
500 Mg
TID
Thinly MSAF, Sp Perneniorrhaphy Of 3rd Degree Laceration
Checking Initial Appropriateness